Ph 2 trial of talimogene laherparepvec (T-VEC) + pembrolizumab in 20 pts w/prev treated loc advanced or metastatic #sarcoma showed overall response rate (ORR) 30% by immune-related RECIST criteria, ORR 35% overall, grade 3 adverse events 20%, no gr 4 tox. ja.ma/2unNV0C

Soft Tissue and Bone Tumours WHO Classification of Tumours, 2020; 5th Edition. From more than 80 to 159 #sarcoma histological subtypes Sarcoma European LatinAmerican Network (SELNET) Sarcoma Cancer Care Foundation SPAGN

Can Biomarkers Guide the Management of Sarcomas? dailynews.ascopubs.org/do/10.1200/ADN… #ASCODailyNews ASCO

Applications are being accepted for the Hematology-Oncology Fellowship program Test Account starting today 7/21/21 to 8/24/21 for the next fellowship year beginning 7/1/22. Watch this video for more information about our program! #HereWithUs youtu.be/upGh8T-d6Og

Updated UCLA pre-op extremity #sarcoma 30 Gy in 5 fractions continue to show excellent outcomes: min 2 years, 6.5% LR, 13% late RT tox, 26.7% major WC. They're teasing 25 Gy in 5 fractions with chemotherapy too 😃 When is it standard? Shauna Campbell, DO Chirag Shah Mudit Chowdhary, MD

Desmoid tumors: Active surveillance in desmoid fibromatosis. bit.ly/3SrAGBB

👩🏼‍⚕️Feb 3, 1821-bday of #DrElizabethBlackwell 👩🏻‍⚕️1st US woman w/med degree (1849) 👩🏽‍⚕️Her med school admit intended as joke 👩🏾‍⚕️Sat alone for lectures, excluded from labs 👩🏿‍⚕️Despite adversities - graduated #1 To women physicians, 👊🏼👊🏾👊🏿 #IamBlackwell #NationalWomenPhysiciansDay #NWPD

A new update on ideas for treating MPNST in Clinical Cancer Research #Sarcoma #hope aacrjournals.org/clincancerres/…